PDPL

Parenteral Drugs (India) Limited has informed the Exchange about Closure of trading window from Thursday, March 31, 2022 till 48 hours after the declaration of Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended March 31, 2022.

Parenteral Drugs (India) Limited has informed the Exchange about One Time Settlement.

Parenteral Drugs (India) Limited has informed the Exchange about change in designation of Chhaya Gupta as Independent Director of the company w.e.f. 01-Mar-2022

Parenteral Drugs (India) Limited has informed the Exchange about Scrutinizer report of Extra Ordinary General Meeting held on 01-Mar-2022

Parenteral Drugs (India) Limited has informed the Exchange about Voting results of Extra Ordinary General Meeting held on 01-Mar-2022

Parenteral Drugs (India) Limited has informed the Exchange about Proceedings of Extra Ordinary General Meeting held on 01-Mar-2022

PDPL:The Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to announcement dated 02-Feb-2022, regarding appointment of Director and Company secretary in the Board meeting held on February 02, 2022. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment2. Brief profile (in case of appointment)3. Whether intimated in 24hrs4. Affirmationﾠthat the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results for the Quarter ended 31st December,2021

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Board meeting held on February 14, 2022.

Parenteral Drugs (India) Limited hereby informs the stock Exchange about Copy of Newspaper Publication related to completion of dispatch of EOGM notice as on 04.02.2022 and matters incidental thereto.

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on March 01, 2022

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on March 01, 2022

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication dated 03.02.2022 for the notice of Extra ordinary .

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on March 01, 2022

Parenteral Drugs (India) Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 25-Feb-2022 to 01-Mar-2022 for the purpose of Meeting.

Parenteral Drugs (India) Limited has informed the Exchange about appointment of Ms Pooja Choukse as Company Secretary/Compliance Officer of the Company w.e.f. from 01/02/2022.

Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.

Parenteral Drugs (India) Limited has informed the Exchange regarding outcome of the Board meeting held on February 02, 2022.

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Parenteral Drugs (India) Limited has informed the Exchange regarding 'OTS'.Change in terms of One Time Loan Settlement Proposal

Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Ms Suruchi Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. January 01, 2022.

Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions

Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mrs Deepali Garehwal as Non- Executive Independent Director of the company w.e.f. November 30, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding publication of Unaudited Financial results for the Quarter and half year ended on 30th September, 2021 in newspaper

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 12, 2021 for approval of Quarterly Unaudited Financial Results ( on both Standalone and Consolidated basis) of the company for the financial year 2021-22 ended on 30th September,2021.

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Parenteral Drugs (India) Limited has informed the Exchange regarding 'Submission of Scrutinizer Report'relating to voting results for 37th Annual General Meeting held on 24th September,2021

Parenteral Drugs (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2021. Further, the company has informed the Exchange regarding voting results.

Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.

Parenteral Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2021

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication for notice of 37th Annual General Meeting

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Annual General Meeting sent to shareholders .

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication relating to Public Notice of 37th Annual General Meeting.

Parenteral Drugs (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2021

Parenteral Drugs (India) Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 17-Sep-2021 to 24-Sep-2021 for the purpose of Meeting.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 26, 2021.

Parenteral Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the Quarter ended 30th June , 2021

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 10, 2021.

Parenteral Drugs (India) Limited has informed the Exchange about related Party Transactions on consolidated basis under Regulation 23(9) of SEBI(Listing Obligations and Disclosure Requirements) Regulation 2015 for the half year ended 31st March, 2021

The Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed.

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

The Exchange has sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.

Parenteral Drugs (India) Limited hereby inform regarding Resubmission of Annual Audited Financial Results on Consolidated basis for the Financial Year ended 31st March, 2021 (XBRL) due to clerical error

Parenteral Drugs (India) Limited has informed the Exchange about Publish Audited Results

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on Jun 30, 2021.

Parenteral Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018